Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.254NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.36.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.79 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.11 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.71 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.33.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.465NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
S.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.215NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.218NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.6 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.5 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.4 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.420NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.168NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.289NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.365NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.252NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.223NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used